Intestinal absorption characteristics and pharmacokinetics of the novel targeted small-molecular NCE in rats

YANG Yang,FAN Chun-mei,ZHANG Jin-kun,HE Xuan,YU Yi-yi,FANG Dai-long,HE Ying-ju,SONG Xiang-rong
2013-01-01
Abstract:Objective: To determine the in-situ intestinal absorption characteristics and pharmacokinetics of 2-methylcarbamoyl-4-{ 4-[3-(trifluoromethyl) benzamido] phenoxy} pyridinium 4-methylbenzenesulfonate monohydrate(NCE) in rats.Methods: Eighteen SD rats were randomly divided into three groups,and their intestines were perfused with NCE(2,20 and 40 μg·mL- 1) by an in-situ rat single-pass intestinal perfusion method.Gravimetric method was used to calculate the intestinal absorption parameters.A single NCE dose of 90 mg·kg- 1was administered to rats intragastrically and intravenously.The concentrations of NCE were determined by HPLC and the main pharmacokinetics parameters were calculated by using DAS 2.1.1 software.Results: The absorbance of NCE was increased with the increasing of NCE concentration.The P app values of the three segments had no significant influence between low and high concentrations.At the same NCE concentration,the K a and P app values in different intestinal segment had no significant influence.The oral absolutely bioavailability of NCE suspension was 44.18%.Conclusion: NCE are absorbed in the whole intestinal tract without absorption selectivity in intestinal segments.The NCE absorption increases with the increasing of concentration within 2 ~ 40 μg·mL- 1,but the P app values of the three segments have no significant influence between low and high concentrations,indicating passive diffusion is the major mechanism of NCE absorption.The oral bioavailability of NCE is temperate,indicating that its oral bioavailability can be improved by pharmaceutical formulation.
What problem does this paper attempt to address?